Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AM001 Cream in Actinic Keratosis
NCT03210740Phase 2Completed
- Sponsor
- AmDerma Pharmaceuticals
- Start
- Jun 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of potassium dobesilate in actinic keratosis (AK), sponsored by AmDerma Pharmaceuticals. Started Jun 2017; status: completed.
02
Drugs
potassium dobesilate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03210740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210740.